Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

BACKGROUND/AIMS: Angiotensin-converting enzyme 2 (ACE2), its product, angiotensin-(1–7) and its receptor, Mas, may moderate the adverse effects of angiotensin II in liver disease. We examined the expression of these novel components of the renin angiotensin system (RAS) and the production and vasoac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Hepatol
Hauptverfasser: Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2007
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114685/
https://ncbi.nlm.nih.gov/pubmed/17532087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2007.03.008
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge